Professor Peter Johnson, nationwide director for most cancers at NHS England, stated: “This implies we now have 4 CAR-T merchandise throughout 5 medical indications, and greater than 1,500 individuals have benefited from these therapies on the NHS at a value reasonably priced to taxpayers.
Supply hyperlink
